Imagine a world in which everyone can contribute to medical research and create safer, less expensive and faster new treatments. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with patients, physicians, care centers, health authorities and the pharmaceutical industry.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

TRIASTEK AND SIEMENS ANNOUNCED A STRATEGIC PARTNERSHIP TO ADVANCE THE PHARMACEUTICAL INDUSTRY'S DIGITAL TRANSFORMATION

Triastek, Inc | March 21, 2022

news image

Triastek, Inc. and Siemens Ltd., China, have agreed to collaborate on digital technologies for the worldwide pharmaceutical business. Triastek's industry-leading 3D printing and digital pharmaceutical technologies, combined with Siemens' worldwide experience in automation and digitalization, should result in unique and disruptive pharmaceutical research and production solutions. Pharmaceutical companies have been encouraged to modernize their manufacturing processes by ado...

Read More

Pharma Tech

CARERX APPLAUDS ONTARIO MINISTRY OF HEALTH'S PAUSE OF PLANNED FEE CHANGES

CareRx | January 18, 2021

news image

CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of specialty pharmacy services to seniors, is pleased that the Ontario Ministry of Health has announced that it will pause for one year previously scheduled changes to long-term care pharmacy funding, which were scheduled to go into effect on April 1, 2021. Under certain amendments to the Ontario Drug Benefit Act that came into effect on January 1, 2020, the reimbursement ...

Read More

Business Insights

TIKOMED AND IQVIA ANNOUNCE A STRATEGIC COLLABORATION FOR THE DEVELOPMENT OF TIKOMED'S LEAD DRUG PLATFORM CANDIDATE ILB®

Tikomed | May 09, 2022

news image

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential in a wide range of diseases driven by acute and chronic inflammation. The collaboration will support TikoMed's clinical development, regulatory and commercial strategies. IQVIA brings together deep therapeutic experti...

Read More

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

news image

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More
news image

Business Insights

TRIASTEK AND SIEMENS ANNOUNCED A STRATEGIC PARTNERSHIP TO ADVANCE THE PHARMACEUTICAL INDUSTRY'S DIGITAL TRANSFORMATION

Triastek, Inc | March 21, 2022

Triastek, Inc. and Siemens Ltd., China, have agreed to collaborate on digital technologies for the worldwide pharmaceutical business. Triastek's industry-leading 3D printing and digital pharmaceutical technologies, combined with Siemens' worldwide experience in automation and digitalization, should result in unique and disruptive pharmaceutical research and production solutions. Pharmaceutical companies have been encouraged to modernize their manufacturing processes by ado...

Read More
news image

Pharma Tech

CARERX APPLAUDS ONTARIO MINISTRY OF HEALTH'S PAUSE OF PLANNED FEE CHANGES

CareRx | January 18, 2021

CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of specialty pharmacy services to seniors, is pleased that the Ontario Ministry of Health has announced that it will pause for one year previously scheduled changes to long-term care pharmacy funding, which were scheduled to go into effect on April 1, 2021. Under certain amendments to the Ontario Drug Benefit Act that came into effect on January 1, 2020, the reimbursement ...

Read More
news image

Business Insights

TIKOMED AND IQVIA ANNOUNCE A STRATEGIC COLLABORATION FOR THE DEVELOPMENT OF TIKOMED'S LEAD DRUG PLATFORM CANDIDATE ILB®

Tikomed | May 09, 2022

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead drug platform candidate ILB®, a broad-spectrum small molecule drug candidate with curative potential in a wide range of diseases driven by acute and chronic inflammation. The collaboration will support TikoMed's clinical development, regulatory and commercial strategies. IQVIA brings together deep therapeutic experti...

Read More
news image

Business Insights

ADITXT, INC. SUCCESSFULLY COMPLETES PRECLINICAL TOXICITY STUDY OF ITS PSORIASIS DRUG CANDIDATE ADI™-100 ADVANCING IT CLOSER TO FIRST-IN-HUMAN TRIALS

Aditxt | July 11, 2022

Aditxt, Inc. a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully completed a toxicology study that indicates the safety profile of ADI™-100, the Company’s immunotherapeutic technology drug that addresses rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. The toxicology findings...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us